No Data
No Data
Nyrada's Brain Injury Drug Candidate Sees Further Positive Result; Shares Down 11%
Strong Domestic Inflation Data Push Down Australian Shares
Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury
Nyrada Begins Animal Testing on NYR-BI03 Brain Injury Program
Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate
Nyrada Raises AU$1.8 Million via Placement
No Data